Skip to main content

Formela Jean Francois's Form 4 filing

Korro Bio, Inc.KRRO · filed Nov 13, 2026

Accession no.
0001030575-26-000016
Filed
Nov 13, 2026, 5:13 PM ET
Trade date
Nov 11-12, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions. Open-market sales total $973.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Formela Jean FrancoisCIK 0001030575Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 11, 2026Common StockSSaleDisposed−19,042$15.00F2−$285,630621,568Indirect
Nov 11, 2026Common StockSSaleDisposed−2,984$15.60F4−$46,550.4618,584Indirect
Nov 11, 2026Common StockSSaleDisposed−3,944$15.00F2−$59,160128,706Indirect
Nov 11, 2026Common StockSSaleDisposed−617$15.60F4−$9,625.2128,089Indirect
Nov 12, 2026Common StockSSaleDisposed−33,175$14.30F6−$474,402.5585,409Indirect
Nov 12, 2026Common StockSSaleDisposed−6,870$14.30F6−$98,241121,219Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.36 to $15.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 2 transactions in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.36 to $15.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 2 transactions in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.95 to $14.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)